Specifically, P-ERK1/2, P-JNK, and P-p38 levels peaked 10 min after OM treatment and gradually decreased at 30 and 60 min, indicating activation of the MAPK pathway in response to OM stimulation (Figure 4C). The gene discussed is MAPK8; the disease is ocular melanoma.